Johnson & Johnson Pharmaceutical Research & Development L L C is categorized under in Exton, PA .
Johnson & Johnson Pharmaceutical Research & Development L L C was established in 0, and today employs 1 to 4, earning Unknown per year. This is a business, which does work in the BOTH market, and is classified as a , under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Jason Van Buren at the company’s branch by writing to 665 Stockton Drive # 104, Exton, Pennsylvania PA 19341 or by phoning (610) 458-2192. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Johnson & Johnson Pharmaceutical Research & Development L L C |
Contact Person: | Jason Van Buren |
Address: | 665 Stockton Drive # 104, Exton, Pennsylvania 19341 |
Phone Number: | (610) 458-2192 |
Website Address: | oncology.janssenrnd.com |
Annual Revenue (USD): | Unknown |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | |
SIC Code: | 2834 |
NAICS Code: | 325412 |
Share This Business: |
Johnson & Johnson Pharmaceutical Research & Development L L C was started in 0 to provide professional under the SIC code 2834 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Jason Van Buren for inquiries that concern Johnson & Johnson Pharmaceutical Research & Development L L C by calling the company number (610) 458-2192, as your correspondence is most welcome. Additionally, the physical location of the branch of Johnson & Johnson Pharmaceutical Research & Development L L C can be found at the coordinates as well as the street address 665 Stockton Drive # 104 in Exton, Pennsylvania 19341.
For its online presence, you may visit Johnson & Johnson Pharmaceutical Research & Development L L C’s website at oncology.janssenrnd.com and engage with its social media outlets through on Twitter and on Facebook.